This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
One agency FDA adviser, resigning from his committee post in protest, called it “probably the worst drug approval decision in recent U.S. Source: STAT News Our healthcare system can’t continue to support drugs that don’t have good clinical outcomes behind them. I, therefore, find the FDA’s decision to be puzzling.
With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. Higher Engagement: Paid search results get twice the clicks of organic results in the healthcare industry.
Understanding Your Audience: Different audiencespatients, healthcare professionals, or payersrequire tailored messages. For instance, while patients prioritize benefits and sideeffects, healthcare providers look for clinical evidence and efficacy. What are the FDA requirements for direct-to-consumer ads?
Introduction Reaching healthcare professionals (HCPs) in the pharmaceutical industry has become increasingly challenging due to strict regulations, evolving digital landscapes, and the growing demand for personalized content. This makes PPC a cost-effective strategy for reaching niche healthcare audiences.
For pharma marketing executives and brand teams, understanding this evolution is essential to remaining competitive and compliant in a rapidly shifting healthcare environment. Modern patient marketing now recognizes the informed, digitally savvy healthcare consumer. For any health issues, always consult a healthcare professional.
Imagine having a tool that allows you to target specific audiences actively searching for healthcare solutions, like branded medications or treatment options. In a world where patients and healthcare professionals (HCPs) search for drug information online, PPC lets you stay top-of-mind. Ensure your ads comply with FDA guidelines.
Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? Reaching Healthcare Professionals (HCPs) HCPs dont search the way patients do.
In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. Todays digitally savvy patients and healthcare professionals expect real-time answers and seamless online experiences.
Are you trying to engage healthcare professionals (HCPs), patients, or caregivers? Both are critical components of effective social media marketing strategies. Ensure you stay compliant with FDA guidelines by including necessary disclaimers. Pharma professionals should take the time to research and segment their audience.
In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. million people in the UK and 2.7
Along with use of the technology to solve healthcare challenges, the company intends to develop it for mundane tasks, such as controlling a computer keyboard or mouse directly using the brain. Take action! Retweet this thread and tell @elonmusk to release the tapes! link] (12/12). — Physicians Committee (@PCRM) November 30, 2022.
Psoriasis is a tricky disease to manage, as drawbacks and sideeffects loom with each and every type of treatment. Food and Drug Administration approved Vtama (tapinarof) cream, an aryl hydrocarbon receptor agonist and the first FDA-approved steroid-free topical medication in its class. Sideeffects, front and centre.
Minor sideeffects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of sideeffects. However, sideeffects do happen. Regarding both common cold and headache, they are as well among the sideeffects reported for similar drugs.
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Pfizer’s Litfulo (ritlecitinib) for treatment for severe alopecia areata in patients 12 years and older. A hard capsule medicine, Litfulo is recommended to be taken daily as one 50mg oral dose. Litfulo’s active ingredient, ritlecitinib, is an enzyme inhibitor.
On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. And, if there are concerns, the pharmacist can call their healthcare provider to develop a plan. Paxlovid in the news.
There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states. This means that hyper-metabolisers would need their dosage to be increased to achieve the desired effect.
On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related sideeffects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.
Non-invasive healthcare products refer to medical devices or technologies that do not require puncturing the skin or entering the body in any way to diagnose, treat, or monitor a health condition. They are designed to be safe and comfortable for patients, and typically have minimal sideeffects.
These treatments at times come with a long list of sideeffects, leaving many patients in search of an effective long-term solution. For some patients with PTSD, psychotherapy may not be an effective option, they may find talking about their traumatic experience stress inducing, untherapeutic or ineffective.
Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.
we must prove the effectiveness of radiopharmaceuticals through clinical trials… This has been demonstrated recently with PLUVICTO… the first US Food and Drug Administration (FDA)-approved targeted radioligand therapy for eligible patients with prostate cancer” At this moment, there is no single treatment for cancer today.
This decision was granted a couple of weeks following approval by the US and Drug Administration (FDA). In August 2024, the European Commission approved EURneffy (adrenaline nasal spray) in the EU as the first needle-free emergency option to treat anaphylaxis. What are the main advantages of EURneffy over similar treatments?
One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. NovaXS is on a mission to simplify the medication self-administration process and improve remote healthcare adherence. billion in 2030 at a CAGR of 9.2%.
The industry has been limited in its ability to implement creative solutions to engage and motivate patients because the FDA has strict guidelines for what pharma companies can communicate with patients. These suboptimal medical sequelae also increase healthcare costs on an individual and industry level. Jason Burum. Priyanka Prakash.
In 1970, the FDA approved ketamine as an anesthetic. Moreover, it can only be used in a certified healthcare setting, not at home. At the same time, titration can reduce the number of sideeffects, says Dr. Albert Dahan, professor of anesthesiology at the University of Leiden, Netherlands.
One potential benefit of cobitolimod’s unique route of administration is that local administration via rectal enema has the potential to limit systemic absorption and the immune-related sideeffects that plague some marketed agents. Abivax is developing obefazimod, another agent with a first-in-class mechanism.
Generics, while FDA-approved, sometimes carried an invisible question mark. The Internal Struggle Dr. Reyes explained the rigorous testing generics go through to ensure they matched the brand name in effectiveness. What if there were unseen sideeffects? Reyes understood the concern. Were they truly the same?
Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential sideeffects of different drugs. The United States Food and Drug Administration (FDA) is the primary regulatory agency that oversees the approval, promotion, and advertising of drugs.
It also underscores the need for patients to communicate openly with their healthcare providers about any health concerns or issues they may have. This includes potential sideeffects or adverse reactions to medications. This is before a drug can be approved for public use.
Engaging with healthcare professionals and patients through educational initiatives and open dialogue helps to demystify complex information and foster a sense of reliability between the two. We asked: • How can transparency and communication play a role in enhancing trust equity for a healthcare sector brand? So, how do we fix this?
Unsurprisingly, the US FDA has reported a noticeable increase in the number of submissions that use AI/machine learning (ML) components in recent years; in 2021, they received more than 100 submissions wherein AI use was reported.
Introduction In the fast-changing world of pharmaceutical marketing , programmatic advertising has revolutionized the way brands reach healthcare professionals (HCPs) and patients. For example, a drug approved by the FDA in the U.S. Geo-targeting ensures ads only appear in locations where they are legally permitted.
Adverse events such as bruising, headaches, and blood in urine occurred at roughly the same frequency in both groups of patients in ADVANCE IV, and while serious sideeffects were seen in 8% of the Vyvgart group, that was lower than the 16% reported with placebo.
There was also continued decline for Tecfidera, which have not been offset by follow-up Vumerity (diroximel fumarate), which has fewer sideeffects. The subcutaneous version still needs to be administered by a healthcare professional. Tecfidera’s decline has made Tysabri Biogen’s top-selling drug.
Obtaining the preferences of patients and their caregivers is not a new concept in healthcare. Increasingly, however, industry guidance documents utilize the term ‘patient preference’ in relation to new drug development and benefit-risk assessment.
In October, the US FDA granted Eli Lilly’s Mounjaro (tirzepatide) a Fast Track designation for its use as a treatment for obesity. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years.
In the competitive landscape of the pharmaceutical industry, effective marketing strategies are crucial for brand success. Pharmaceutical marketing is not just about reaching healthcare professionals and patients; it involves a complex interplay of understanding market dynamics, regulatory compliance, and leveraging digital platforms.
In October, the US FDA granted Eli Lilly’s Mounjaro (tirzepatide) a Fast Track designation for its use as a treatment for obesity. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. NICE has only allowed healthcare providers to prescribe continuous treatment of the drug for two years.
Marketing for these innovations requires educating both healthcare professionals (HCPs) and patients about their benefits. FDA and EMA Updates: Regularly monitor guidelines from agencies like the FDA (U.S.) Disclosing sideeffects and potential risks builds credibility.
Three effective strategies that have been proven to work are: Developing personalized patient-friendly resources that are easy to understand. Support healthcare providers in a real and personal way. It is a bridge between where we are in healthcare today and where we want to go tomorrow. print, online, video).
By understanding these strategies, stakeholders in the pharmaceutical industry can better navigate the complexities of promoting their products effectively. One of the primary objectives of pharma marketing is to communicate the benefits and safety profiles of medications to healthcare providers and patients.
The biologic treatment was granted approval as Kisunla (donanemab-azbt) in the US by the Food and Drug Administration (FDA) in July 2024. Nevertheless, both efficiently clear amyloid and have a similar slowing effect on progression of cognitive decline in patients”.
A generic here will improve access in OAB to a product with less sideeffects, which is especially important in the elderly population, Casberg noted. In March, the FDA approved several new naloxone products using the pathway, including one from Amphastar, which will compete with other intranasal on the market.
In order to advance the effective delivery of healthcare for individuals, health information systems must work together within and across organizational boundaries. Internally, this means updating legacy systems and combining multiple data sources like ERP and marketing/sales systems needed to be effective.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content